(IN BRIEF) Roche has announced new data at the Euretina Congress in Paris from its AVONELLE-X and SALWEEN studies of Vabysmo (faricimab), confirming the therapy’s strong long-term outcomes for patients with retinal diseases. The AVONELLE-X study, the largest long-term extension … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged AVONELLE-X, bispecific antibody, diabetic macular edema, DME, durability, Euretina Congress, extended dosing, faricimab, Levi Garraway, long-term efficacy, LUCERNE, nAMD, neovascular age-related macular degeneration, ophthalmology, PCV, polypoidal choroidal vasculopathy, retinal vein occlusion, Roche, RVO, SALWEEN, TENAYA, Vabysmo, vision loss
(IN BRIEF) ZEISS Medical Technology has received CE mark approval for CIRRUS PathFinder, an integrated AI decision support tool for optical coherence tomography (OCT). The software, available as part of a new CIRRUS update, leverages deep learning algorithms to automatically … Read the full press release
Posted in Artificial Intelligence (AI), Business, Electronics & Machinery, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged AI in healthcare, Anuj Kalra, CE Mark, CIRRUS PathFinder, clinical decision support, Cybersecurity, deep learning, diagnostic imaging, digital health, Euan S. Thomson, eye care, Magnus Reibenspiess, medical technology innovation, OCT, OCTA, ophthalmology, ZEISS Medical Technology
(PRESS RELEASE) SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EuropaWire/ — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts … Read the full press release
Posted in Austria, Germany, Healthcare, Hungary, News, Pharma & Biotech, Science
Tagged anti-allergic medication Pollival, anti-COVID therapeutics, antihistamine drug, antiviral properties, azelastine, azelastine hydrochloride, CEBINA GmbH, Central European Biotech Incubator and Accelerator, clinical trial, COVID-19, COVID-19 medication, Covid-19 pandemic, COVID-19 treatment, nasal spray, ophthalmology, Pollival, Prof Dr Robert Konrat, Prof Dr. Ferenc Jakab, re-purpose drugs, SARS-CoV-2, Sophie Zettl, University of Pécs, University of Vienna, URSAPHARM Arzneimittel GmbH, viral spread
Alcon SMART Suite, powered by Philips’ HealthSuite digital platform, aims to drive innovation in ophthalmology delivering personalized and seamless end-to-end care for cataract patients AMSTERDAM, 24-Oct-2018 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?